Atlas Trials

Early Biomarker With 18F-FDG PET for Treatment Optimization of Anti-EGFR Therapy in Patients With Metastatic Colorectal Cancer.

Clinical trial NCT01691391 · COMPLETED

Trial details

NCT number
NCT01691391
Sponsor
Amsterdam UMC, location VUmc
Status
COMPLETED
Study type
OBSERVATIONAL
Colorectal Cancer
Start date
2012-01-01
Primary completion
2020-11-03
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.